Showing results (121-130 of 207) with videos related to
Sort By:
Pageof 21
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2008
Preprocalcitonin signal peptide generates a cytotoxic T lymphocyte-defined tumor epitope processed by a proteasome-independent pathwayFaten El Hage, Vincent Stroobant, Isabelle Vergnon, et al.Oncogene|October 17, 2003
Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinomaGuillaume Dorothée, Hamid Echchakir, Béatrice Le Maux Chansac, et al.Critical Reviews in Immunology|April 20, 2019
Tumor Hypoxia: A Key Determinant of Microenvironment Hostility and a Major Checkpoint during the Antitumor ResponseAmirtharaj Francis, Goutham Hassan Venkatesh, Rania Faouzi Zaarour, et al.Bulletin Du Cancer|November 12, 2003
[Tumor/cytotoxic effector cross-talk in the control of tumor susceptibility to lysis]Asma Gati, Guillaume Dorothée, Jérôme Thiéry, et al.Blood|March 6, 2002
Leukemic target susceptibility to natural killer cytotoxicity: relationship with BCR-ABL expressionFrédéric Baron, Ali G Turhan, Julien Giron-Michel, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
The decreased susceptibility of Bcr/Abl targets to NK cell-mediated lysis in response to imatinib mesylate involves modulation of NKG2D ligands, GM1 expression, and synapse formationChristelle Cebo, Sylvie Da Rocha, Sebastian Wittnebel, et al.International Immunology|April 29, 2008
Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathwayBéatrice Le Maux Chansac, Dorothée Missé, Catherine Richon, et al.Cancer Research|September 12, 2015
Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor CellsSanam Peyvandi, Stéphanie Buart, Boubekeur Samah, et al.Cancer Research|December 3, 2008
ICAM-1 has a critical role in the regulation of metastatic melanoma tumor susceptibility to CTL lysis by interfering with PI3K/AKT pathwayAhmed Hamaï, Franck Meslin, Houssem Benlalam, et al.Oncoimmunology|November 21, 2015
miR-181a modulates acute myeloid leukemia susceptibility to natural killer cellsArash Nanbakhsh, Géraldine Visentin, Daniel Olive, et al.Pageof 21